PRIVATE SECTOR DRIVEN PUBLIC-PRIVATE PARTNERSHIPSAfrica Health Business Symposium, 6 November 2017Soraya Ramoul, Director, Novo Nordisk

Health is essential for Sustainable Development

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well being.

Achieve universal health coverage, including financial risk protection, access to quality essential healthcare services and access to safe, effective, quality and affordable essential medicines and vaccines for all.

Encourage and promote effective public, public-private and civil society partnerships,

Three key targets from Sustainable Development Goals for Novo Nordisk:

The diabetes challenge in Africa1

20 MILLIONADULTS HAVE DIABETES

6 OUT OF 10ADULTS WITH TYPE 2 DIABETESdo not know they have it

BY 2040 THIS FIGURE COULD RISE TO

46 MILLION378,000PEOPLE DIED OF DIABETES-RELATED CAUSES IN 20151

1. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. 2015 Update Brussels, Belgium: International Diabetes Federation. 2015.

Diabetes causes more deaths than many communicable diseases combined1,2

Presentation title Date 4

1. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. 2015 Update Brussels, Belgium: International Diabetes Federation. 2015. 2. WHO Global Health Observatory Data Repository 2013

5 milliondeaths1

1.5 million deaths2

1.5 million deaths2

0.6 million deaths2

Diabetes HIV/AIDS Tuberculosis Malaria

People with diabetes require access to a range of services and support to manage their diabetes1,2

medicinesfor managing blood sugar levels

and other comorbidities1,2

equipment and suppliesfor monitoring blood sugar

levels2

healthcareprofessional supportto manage and adjust

treatment2

educationto empower people to manage their diabetes2

healthy lifestyle interventionsto promote healthy living and reduce the risk of complications2

regular screeningfor early detection and treatment of diabetes-related complications2

1. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. 2015 Update Brussels, Belgium: International Diabetes Federation. 2015. 2. WHO Global Health Observatory Data Repository 2013

We are working in partnership to develop solutions that

increase access to diabetes care in support of the SDGs

Novo Nordisk is working in partnership to improve access to diabetes care

Access to Insulin CommitmentOur commitment to have low-cost insulin in our product portfolio and to make human insulin available to low-income countries and humanitarian organisations.*

RANJITH SRanjith has type 1 diabetes

and lives in India

7SARAH AHMEDSarah has type 1 diabetes

and lives in Ethiopia

We provide human insulin at a guaranteed ceiling price not exceeding 20% of the list price in the Western world.

2017 maximum price 4 USD/vial

* Least developed countries (as defined by the United Nations), other low-income countries (as defined by the World Bank) and selected organisations providing relief in humanitarian situations.

The Access to Insulin Commitment Applicable in 50 countries and to humanitarian organisations

8

LDCs as per the UN 2016 and LICs as per the World Bank 2017

Changing Diabetes®

in ChildrenThe programme provides access to care, including human insulin free of cost, to children with type 1 diabetes.

Activities run in 14 low- and middle-income countries* in collaboration with international and local partners.

RANJITH SRanjith has type 1 diabetes

and lives in India

* Bangladesh, India, Cameroon, Democratic Republic of the Congo, Ethiopia, Guinea, Kenya, Tanzania, Uganda, Senegal, Ivory Coast, Sudan, Myanmar and Cambodia

1. Data on file. Novo Nordisk A/S, 2017.Numbers are as of December 2016.

108clinics established1

14,000children enrolled1

>8,500healthcare

professionals trained1

9

Changing Diabetes® in Children

Global partners Local partners

10

Ministry of health

Civil society (diabetes associations and local NGOs)

Local diabetes experts

Changing Diabetes®

in Pregnancy

CELESTE SMITHCeleste has gestational diabetesand lives in South Africa

The Changing Diabetes® in Pregnancy programme is advocating for improved, testing, care and education for women with gestational diabetes (GDM) in low- and middle-income countries.

181,296women reached

through awareness raising1

48,142 women screened

for GDM1

4,243healthcare

professionals trained1

1. Data on file. Novo Nordisk A/S, 2017Numbers are as of December 2016.

DIANA TORRECILLADiana had gestational diabetes in her third pregnancy andlives in Colombia

The Base of the Pyramid programme works to improve access to diabetes care for the working poor at the base of the economic pyramid.

The programme runs in three countries.*Interventions range from ensuring stable and affordable supply of insulin to establishing diabetes clinics and centres of excellence.

Reaching the base of the pyramid

* Ghana, Kenya and Nigeria

Diabetes screening in Ghana

12

1,650 HCPs trained1

millionpeople reached with

awareness campaigns1

5,600patients

receiving insulin1

2

1. Data on file. Novo Nordisk A/S, 2017.Numbers are as of December 2016.

World Diabetes Foundation

The WDF operates independently of Novo Nordisk. The WDF funds projects on diabetes prevention and treatment in developing countries.

The grant to WDF is our biggest investment in improving access to care in developing countries.

SUSANNE BRIXTOFTE OLEJAS, WDF Programme Coordinator (right) greets a project partner during a WDF field visit to Cote d’Ivoire in 2013

Awaits new pic from GWC

13

1. www.worlddiabetesfoundation.org/who-we-are. Accessed May 2017. 2. World Diabetes Foundation. Annual Review 2016.

Numbers are as of December 2016.

USD 122million1

projects funded1

+334,000 HCPs trained2

486

Thank You